Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Raul Hernandes Bortolin, Ph.D., Pharm.D.

Concepts (273)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Raul Bortolin's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Raul Bortolin has written about over time.
Bone Resorption, 1 publications between 2015 and 2015, average publication date April 2015. Osteocalcin, 2 publications between 2015 and 2016, average publication date February 2016. Zinc, 2 publications between 2015 and 2017, average publication date April 2016. Bone Density, 4 publications between 2015 and 2017, average publication date May 2016. Osteoprotegerin, 3 publications between 2015 and 2017, average publication date June 2016. Anabolic Agents, 1 publications between 2016 and 2016, average publication date November 2016. Matrix Metalloproteinase 9, 3 publications between 2015 and 2018, average publication date January 2017. Dietary Supplements, 3 publications between 2015 and 2020, average publication date September 2017. Diabetes Mellitus, Type 1, 9 publications between 2015 and 2022, average publication date December 2017. Rats, Wistar, 9 publications between 2015 and 2019, average publication date December 2017. Diabetes Mellitus, Experimental, 7 publications between 2015 and 2021, average publication date January 2018. RNA, Messenger, 10 publications between 2015 and 2022, average publication date May 2018. Tamarindus, 2 publications between 2018 and 2019, average publication date January 2019. MicroRNAs, 8 publications between 2016 and 2023, average publication date April 2020. Brazil, 12 publications between 2017 and 2023, average publication date July 2020. Hyperlipoproteinemia Type II, 8 publications between 2020 and 2024, average publication date November 2022. Myocytes, Cardiac, 2 publications between 2024 and 2024, average publication date July 2024. Calmodulin, 1 publications between 2024 and 2024, average publication date August 2024. Oligonucleotides, Antisense, 1 publications between 2024 and 2024, average publication date August 2024.

To see the data from this visualization as text, click here.
Bortolin's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (273)
Explore
_
Co-Authors (22)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.